Kalirin, a Cytosolic Protein with Spectrin-like and GDP/GTP Exchange Factor-like Domains That Interacts with Peptidylglycine alpha -Amidating Monooxygenase, an Integral Membrane Peptide-processing Enzyme*

(Received for publication, February 3, 1997, and in revised form, March 5, 1997)

M. Rashidul Alam , Richard C. Johnson , Daniel N. Darlington Dagger , Tracey A. Hand , Richard E. Mains and Betty A. Eipper §

From the Departments of Neuroscience and Physiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 and the Dagger  Departments of Surgery and Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Although the integral membrane proteins that catalyze steps in the biosynthesis of neuroendocrine peptides are known to contain routing information in their cytosolic domains, the proteins recognizing this routing information are not known. Using the yeast two-hybrid system, we previously identified P-CIP10 as a protein interacting with the cytosolic routing determinants of peptidylglycine alpha -amidating monooxygenase (PAM). P-CIP10 is a 217-kDa cytosolic protein with nine spectrin-like repeats and adjacent Dbl homology and pleckstrin homology domains typical of GDP/GTP exchange factors. In the adult rat, expression of P-CIP10 is most prevalent in the brain. Corticotrope tumor cells stably expressing P-CIP10 and PAM produce longer and more highly branched neuritic processes than nontransfected cells or cells expressing only PAM. The turnover of newly synthesized PAM is accelerated in cells co-expressing P-CIP10. P-CIP10 binds to selected members of the Rho subfamily of small GTP binding proteins (Rac1, but not RhoA or Cdc42). P-CIP10 (kalirin), a member of the Dbl family of proteins, may serve as part of a signal transduction system linking the catalytic domains of PAM in the lumen of the secretory pathway to cytosolic factors regulating the cytoskeleton and signal transduction pathways.


INTRODUCTION

Cytosolic proteins are involved in the formation of secretory granules (1-6) and in the trafficking and localization of integral membrane proteins needed for the synthesis of bioactive peptides (7-16). We have used one of the few integral membrane proteins known to be involved in the biosynthesis of neuropeptides, peptidylglycine alpha -amidating monooxygenase (PAM),1 to search for cytosolic proteins involved in these processes (17). PAM is a bifunctional enzyme and integral membrane forms contain an NH2-terminal signal sequence, the two catalytic domains that catalyze the sequential reactions required for peptide amidation, a single transmembrane domain, and a short cytosolic domain (18).

PAM is involved in the production of all alpha -amidated peptides and functions only after neuroendocrine-specific endoproteases and carboxypeptidases have exposed the COOH-terminal glycine residue that serves as the nitrogen donor for amide formation (19). Immunocytochemical evidence indicates that PAM begins to function in the trans-Golgi network (TGN), but most peptide amidation occurs in immature secretory granules (20). Using immunoelectron microscopy, integral membrane forms of PAM have been localized to the TGN, especially to distal tubuloreticular regions, and to large dense core vesicles (21).

When expressed independently in neuroendocrine cells, each lumenal catalytic domain of PAM is targeted to large dense core vesicles (22). Integral membrane forms of PAM are localized to the TGN region of both neuroendocrine and nonneuroendocrine cells (7, 8). A small percentage of membrane PAM is present on the cell surface or in endosomes at steady state. Elimination of the distal 40 amino acids of the 86-amino acid cytosolic domain results in relocation of membrane PAM to the plasma membrane (8, 9). When transferred to a plasma membrane protein such as the interleukin 2 receptor alpha -chain (Tac), the cytosolic domain of PAM directs the majority of the protein to the TGN region and confers the ability to undergo internalization from the plasma membrane (9).

Mutation of a tyrosine residue in the COOH-terminal domain of PAM greatly diminishes internalization of PAM from the cell surface without dramatically altering its TGN localization (9). The TGN localization of membrane PAM is greatly compromised upon deletion of an 18-amino acid domain that includes the tyrosine residue essential for internalization. Integral membrane PAM proteins are phosphorylated, and mutagenesis studies indicate that phosphorylation affects routing (23).

Using a rat hippocampal library and the yeast two-hybrid system, we recently identified partial cDNAs encoding two PAM COOH-terminal interactor proteins (P-CIPs) (17). The biological relevance of these interactions is supported by the fact that the interactions are eliminated when the 18-amino acid segment identified as essential for proper routing of PAM is eliminated. P-CIP2 is similar to serine/threonine dual specificity protein kinases, while P-CIP10 contains at least five spectrin-like repeats (17). In this study we identify the full-length P-CIP10 protein as a member of the Dbl family of GDP/GTP exchange factors (24) and establish the phenotype of stably transfected AtT-20 cell lines expressing PAM-1 and P-CIP10.


MATERIALS AND METHODS

Cloning of Full-length P-CIP10 cDNAs

The 2.0-kb P-CIP10 cDNA fragment identified using the yeast two-hybrid system (17) was used to screen 1 × 106 plaque-forming units from a random primed rat hippocampal cDNA library in lambda -ZAPII (Stratagene). Seven positive clones were plaque-purified, and the two largest cDNA inserts recovered were overlapping 4.7-kb (clone 10/28) and 4.1-kb (clone 10/34) fragments. Both strands of these cDNAs were sequenced completely; only the 5' ends of clones 10/28 (upstream sequence from nucleotide 36) and 10/34 (upstream sequence from nucleotide 419) differed. Attempts to extend these sequences by 5'-rapid amplification of cDNA ends (RACE) were unsuccessful. The five shorter cDNAs were fragments of the larger pieces. DNA manipulations were carried out according to standard protocols.

Since no in-frame stop codon was identified in clones 10/28 and 10/34, 3' RACE was used to extend the 3'-end of the 10/28 cDNA (25). Briefly, poly (A)+ RNA from adult rat parietal cortex (200 ng) or olfactory bulb (140 ng) was reverse transcribed with the Promega reverse transcription system (Madison, WI) using a RACE hybrid primer (RHP) 5'-GGAATTCGAGCTCATCGAT17-3' (0.75 µM) and avian myeloblastosis virus reverse transcriptase (15 units). After the initial 35-cycle amplification using 5'-CAGGATGCCTTTCAAGTG-3' (nt 4375-4392 of final P-CIP10a) and RHP, an aliquot of the PCR product was used in a nested PCR with 5'-CCTCTAGAGCACCCCATCCTCAGACAAT-3' (nt 4592-4611 of P-CIP10a) and RHP. A 770-base pair fragment (674 nt of new sequence) from independent amplifications of both tissues was purified, subcloned into pBluescript II (SK-) (pBS), and sequenced. The additional 3'-sequence contained no in-frame stop codon, so 3'-RACE was repeated as above using sense primers 5'-CTGCTTCTTCCCCCTGGTGA-3' (nt 5097-5116 of P-CIP10a) for the first round of amplification and 5'-GGTCTAGAATGGAGGCAAGTCTGAGT-3' (nt 5144-5164 of P-CIP10a) for the second round of PCR reactions with the same RHP. The 650-base pair fragment (444 nt of new 3' sequence) obtained in this second 3'-RACE reaction had an in-frame stop codon. Reverse transcriptase-PCR was used to verify that the novel sequence contained in the 3'-RACE products was contiguous to clone 10/28.

Full-length P-CIP10a (10/28 cDNA at the 5' end) and P-CIP10b (10/34 cDNA at the 5' end) cDNAs were constructed using a PCR-generated pBS.P-CIP10-3' (nt 4255-5724) intermediate. Full-length P-CIP10a cDNA (pBS.P-CIP10a) was created by a three-way ligation of Bsp106I/BamHI-digested pBS, a 4.45-kb fragment obtained from clone 10/28 by digestion with Bsp106I (5'-MCS)-AspEI (nt 4401) and a 1.32-kb fragment obtained from AspEI/BamHI-cut pBS.P-CIP10-3'. To create the full-length P-CIP10b cDNA (pBS.P-CIP10b), clone 10/34 was digested with BstBI (nt 2674) and XbaI (3'-MCS), and the 10/34 sequence downstream of BstBI was replaced with the 3.4-kb BstBI (nt 2291 of P-CIP10a)-XbaI (3'-MCS) fragment from pBS.P-CIP10a.

Construction of Expression Vectors

Construction of pGEX-CIP10, an expression vector encoding a GST fusion protein containing P-CIP10a (aa 447-1138), was described (17). To construct pET-HisDH, a bacterial expression vector encoding all of the Dbl homology (DH) domain and most of the pleckstrin homology (PH) domain of P-CIP10a (P-CIP10a (aa 1254-1537)), the 857-base pair fragment from clone 10/28 was subcloned into pET28a (Novagen) in-frame with the histidine tag. A mammalian expression vector encoding full-length P-CIP10a (pSCEP.P-CIP10a) was constructed by inserting the full-length cDNA piece from pBS.P-CIP10a into pSCEP (26). To construct pBS.Myc.P-CIP10, the c-Myc epitope (underlined) with a Gly5 linker (MEQKLISEEDLNGGGGG) was joined in-frame to Gly5 of P-CIP10a using standard methods. The full-length cDNA insert was then transferred to pSCEP to generate p.SCEP.Myc.P-CIP10. All PCR-generated cDNA was confirmed by DNA sequencing.

In Vitro Transcription/Translation and Northern Blot Analysis

Truncated forms of P-CIP10 cDNAs were used as templates for in vitro transcription and translation reactions. pBS.10a (nt 1-1142) was generated by digesting pBS.P-CIP10a with BglII (cuts at nt 1142) and BamHI (cuts in 3'-MCS) and religating. pBS.10b (nt 1-1525) was generated in the same manner from pBS.P-CIP10b. Radiolabeled proteins ([35S]methionine, 40 µCi/40-µl reaction; Amersham Corp.) were synthesized using a rabbit reticulocyte lysate in vitro transcription and translation system (TNT; Promega Corp.) and analyzed by SDS-PAGE with or without prior immunoprecipitation. Total RNA (10 µg) prepared from different adult rat tissues was electrophoresed on 1% agarose gels containing formaldehyde (25). Poly(A)+ RNA was prepared with the Promega PolyATtract® mRNA isolation system II. RNA transferred to nitrocellulose membranes was hybridized with a cDNA probe encompassing nt 1363-3398 of P-CIP10a using standard protocols (25). In situ hybridization was carried out as described (17).

Antibodies

Monoclonal antibody 6E6 recognizes PAM COOH-terminal cytosolic domain (CD) (9). Rabbit polyclonal antibody JH1764 was generated by immunization of adult female rabbits with purified recombinant rat PHM (aa 37-382) and recognizes native PHM (21). Rabbit antibody JH2007 was raised to a synthetic polypeptide (P-CIP10a (aa 992-1013)) linked to keyhole limpet hemocyanin with glutaraldehyde (Hazleton HRP, Inc., Denver, PA) (27). Rabbit polyclonal antibody JH2000 was raised by immunization with GST.P-CIP10a (aa 447-1138). The fusion protein purified by SDS-PAGE and electroelution was used as antigen. Antibody JH2000 recognizes full-length P-CIP10 only after denaturation. Monoclonal antibody 4C9 was generated to recombinant P-CIP10a (aa 1254-1537) (His-DH) expressed in Escherichia coli and purified by adsorption to nickel-bound His-Bind resin (Novagen) (9). Monoclonal antibody 9E10 to the Myc epitope (28) was prepared from conditioned medium or ascites fluid (Hazleton, HRP).

Cell Culture and Cell Lines

All cells were cultured in Dulbecco's modified Eagle medium/F-12 containing 10% fetal bovine serum (Hyclone, Logan, UT) and 10% Nu serum (Collaborative Research, Bedford, MA). Transfected cell lines were grown with appropriate drug selection: G418 (0.5 mg/ml) for pMt.Neo or pMc.Neo (Stratagene, La Jolla, CA) cotransfections; hygromycin (200 units/ml) for pCEP4 (Invitrogen) or pSCEP (26) cotransfections. AtT-20/PAM-1 cells were transfected with pSCEP.P-CIP10a or pSCEP.Myc.P-CIP10a using lipofection. Cells resistant to both hygromycin and G418 were selected, expanded, and screened for expression of P-CIP10 or Myc.P-CIP10 transcript by Northern blot analysis. Cell lines were subcloned and again screened by Northern blot analysis.

Biosynthetic Labeling, Subcellular Fractionation, and Immunoprecipitation

Cells plated on 15-mm culture dishes and grown to 70-90% confluency were incubated in methionine/cysteine-free complete serum-free medium for 10 min and then labeled with the same medium containing 1 mCi/ml [35S]methionine/cysteine (ProMix; Amersham) for 15 or 30 min followed by a nonradioactive chase in complete serum-free medium. Cells were either directly extracted into SDS buffer (1% SDS, 50 mM Tris-HCl, pH 7.5, 10 mM beta -mercaptoethanol) by incubation at 95 °C for 5 min or were scraped into TMT buffer (10 mM sodium TES, pH 7.5, 20 mM mannitol, 1% Triton X-100) and subjected to three cycles of freezing and thawing and centrifugation to pellet insoluble material. For the subcellular fractionation experiment, cells were removed from the dishes by scraping into an isotonic buffer (50 mM HEPES-KOH, pH 7.5, 250 mM sucrose), disrupted using a ball bearing cell cracker (15-µm clearance), and subjected to differential centrifugation (23).

Immunoprecipitation of P-CIP10 utilized Ab JH2000 or Myc mAb 9E10 (23, 28). PAM-1 was immunoprecipitated using Ab JH1764 (22). Immunoprecipitated proteins were resolved by SDS-PAGE and visualized by fluorography. Apparent molecular masses were determined using prestained molecular weight standards (Rainbow standards; Amersham). The capacities of Ab JH2000 and mAb 9E10 were determined by adding increasing amounts of AtT-20/P-CIP10a or AtT-20/Myc.P-CIP10 cell extract to a fixed amount of antibody plus radiolabeled in vitro translated Myc.P-CIP10.

Morphological Studies of Stably Transfected Cells

Live AtT-20 cells were photographed at low magnification using phase contrast optics. Coded images were analyzed using a BioQuant TCW (version 3.00; R & M Biometrics, Nashville, TN) to record the total number of cells, number of cells with processes (longer than 1 cell body length), number of round cells, number of giant cells (cell body bigger than 3 nuclei), length of each process, and number of bifurcations (branch points). Four or five images were analyzed for each cell line (215-460 cells); after decoding, data were analyzed for statistical significance using a t test.

Complex Formation of GST-GTPases with P-CIP10

E. coli transformed with vectors encoding GST-Rac1, GST-RhoA, and GST-Cdc42Hs were obtained from Dr. Richard C. Cerione (Cornell University, Ithaca, NY). The purified fusion proteins were prepared, dialyzed, bound to glutathione-Sepharose beads, and depleted of bound nucleotide (29, 30). AtT-20 cells expressing PAM-1 or PAM-1 with Myc.P-CIP10 were extracted into 20 mM Tris-HCl, pH 7.5, 50 mM NaCl containing 1% Triton X-100. After freezing and thawing three times, extracts were diluted with 3 volumes of the guanine-nucleotide depletion buffer (30) and centrifuged. For each binding reaction, about 50 µg of GST-GTPase bound to 50 µl of glutathione-Sepharose beads was mixed with an aliquot of cell extract containing 2 mg (0.25 mg/ml) of protein from nonlabeled cells or 5 × 107 cpm/ml acid-precipitable protein from radiolabeled cells. After mixing for 3 h at 4 °C, the beads were washed with nucleotide depletion buffer. The beads incubated with nonlabeled extracts were eluted with Laemmli buffer, and bound proteins were subjected to SDS-PAGE and Western blot analysis using Ab JH2000. The beads incubated with radiolabeled cell extracts were eluted by boiling in 50 mM Tris-HCl, pH 7.5, 1% SDS, diluted, and subjected to immunoprecipitation (9) with Ab JH2000.


RESULTS

Tissue Distribution of P-CIP10 mRNA

P-CIP10 was identified in a hippocampal/cortical cDNA library prepared from 3-week-old rat pups that had been subjected to a single maximal electroconvulsive stimulus (17). Before trying to clone a full-length P-CIP10 cDNA, we used Northern blot analysis to determine the size of the P-CIP10 transcript and the tissues expressing the highest levels of P-CIP10 (Fig. 1A). A somewhat heterogeneous set of P-CIP10 transcripts was visualized in total RNA prepared from olfactory bulb, parietal cortex, and hippocampus, with lower levels detected in hypothalamus and none detected in cerebellum. P-CIP10 mRNA was detectable in total RNA prepared from kidney and spleen but was not visualized in anterior or neurointermediate pituitary or atrium, tissues that contain high levels of PAM mRNA. Multiple forms of P-CIP10 mRNA were apparent in all of the tissues examined; when poly(A)+ mRNA from olfactory bulb and parietal cortex was subjected to Northern blot analysis, distinct bands of 8.0 and 5.7 kb were detected (Fig. 1A, inset).


Fig. 1. Expression of P-CIP10 mRNA is prominent in specific brain regions. A, total RNA (10 µg) from the indicated adult rat tissues was subjected to Northern blot analysis. P-CIP10 transcripts were visualized with the P-CIP10 (nt 1363-3398) probe (17). Inset, poly(A)+ RNA (8 µg) was visualized with the same probe. P-CIP10 transcripts were visualized in a coronal section through the anterior hypothalamic area (B) or the olfactory bulb (D) using an antisense riboprobe; the sense riboprobe control for a corresponding section is shown for comparison (C). AOB, accessory olfactory bulb, IGr; internal granular layer, IPl; internal plexiform layer, Mi; mitral cell layer, EPl; external plexiform layer, Gl; glomerular layer. Bar, 200 µm.
[View Larger Version of this Image (83K GIF file)]

A similar distribution of P-CIP10 transcripts was observed when in situ hybridization was performed on sections of adult rat brain (Fig. 1, B and D). P-CIP10 transcripts were prevalent in the olfactory bulb, including the internal granular layers, internal plexiform layer, mitral cell layer, and accessory olfactory bulb. P-CIP10 transcripts were also prevalent in all layers of the cerebral cortex, piriform cortex, and amygdala and in the dentate gyrus and CA1-3 regions of the hippocampus. P-CIP10 transcripts were present at lower levels in several hypothalamic structures, including the paraventricular, supraoptic, dorsomedial, and arcuate nuclei.

Isolation of Full-length P-CIP10 cDNAs

Our partial cDNA was substantially shorter than the P-CIP10 mRNAs observed in tissues. We used the 2.0-kb P-CIP10 cDNA fragment to screen a rat hippocampal cDNA library. The two largest cDNA fragments isolated (10/28 and 10/34) were identical except at their 5'-ends (Fig. 2A). No in-frame stop codons were found at either end of either cDNA. The GC content of the 5'-ends of both clones was high, and attempts to extend the sequences by 5'-RACE were unsuccessful (25); sequence and in vitro translation data (see below) indicated that an initiator Met was included in each clone. By sequentially employing 3'-RACE, we extended the sequence to include an in-frame stop codon (Fig. 2A). No sequence diversity was found in the newly amplified 3'-fragments. The fragments were assembled to form two full-length P-CIP10 cDNAs, P-CIP10a (5'-end of 10/28) and P-CIP10b (5'-end of 10/34) (Fig. 2A).


Fig. 2. Cloning strategy, in vitro transcription/translation, and sequence of P-CIP10. A, the partial cDNAs isolated from the yeast two-hybrid PAM CD interactor screen, I-10 and I-19, are indicated. Using I-10 (P-CIP10 (nt 1363-3398)) as probe, cDNAs 10/34 and 10/28 were isolated from a rat brain cDNA library. RACE products 1 and 2 (RACE#1 and RACE#2) were obtained through sequential use of 3'-RACE. P-CIP10a and P-CIP10b were constructed from clones 10/28 and 10/34 with RACE products 1 and 2. B, the nucleotide sequences at the putative translational initiation sites in P-CIP10a and P-CIP10b are compared with the optimal translational initiation site (Kozak) (31, 32); identities are in boldface type. C, for in vitro transcription/translation, pBS.10a (nt 1-1142) and pBS.10b (nt 1-1525) were used as templates. The SDS-PAGE analysis and apparent molecular masses of the translation products are shown; the molecular mass predicted for each translation product is shown in parenthesis. D, amino acid sequence obtained by translating the longest open reading frame of the P-CIP10a cDNA (U70373; P-CIP10b is U88156). The protein sequence reported previously (aa 447-1138) (17) is set off by arrows with double bars; the sequence marked above by a cross-hatched bar is P-CIP19 (aa 473-823). The boxed region (aa 992-1013) shows the peptide used to raise antisera. The beginning and end of each spectrin-like repeat is indicated by double-headed arrows. DH and PH domains are overlined with thick and thin lines, respectively. The triplet encoding Lys1794 was absent in approximately half of the PCR products sequenced, presumably reflecting a splicing variant. Probable human P-CIP10 clones were identified by screening dbEST and dbSTS; the regions of rat P-CIP10 to which the human ESTs correspond are indicated by dots under the sequence, and sites at which the amino acid sequence predicted for human P-CIP10 differs from that of rat P-CIP10 are indicated. a, AA028043; b, AA027938, four frame shifts inserted; c, H09892; d, AA115289, one frame shift, and AA115265. E, major domains of rat P-CIP10 are drawn to scale.
[View Larger Version of this Image (60K GIF file)]

A single long open reading frame with a stop codon near the 3'-end was found in both P-CIP10 cDNAs. The GC-rich nature of the 5'-end of both P-CIP10a and P-CIP10b and the presence of a single Met residue in both unique regions raised the possibility that a transcriptional start site was present in each clone. The nucleotide sequence surrounding each Met agreed with the consensus translational initiation sequence defined for higher eukaryotes (Fig. 2B) (31, 32). To determine whether these potential translational initiation sites were functional, we performed coupled in vitro transcription/translation reactions. We truncated P-CIP10a and P-CIP10b at a common site less than 1200 nt from the potential translational initiation sites so that the predicted 20-amino acid difference between the translation products of P-CIP10a and P-CIP10b would be detectable (Fig. 2B). Each P-CIP10 cDNA yielded a protein of the size predicted if translation were initiated at the Met in each unique 5'-region (Fig. 2C); for both P-CIP10a and P-CIP10b, the next Met is more than 80 amino acid residues downstream. The P-CIP10a transcription/translation reaction proceeded much more efficiently than the P-CIP10b reaction, and we used the P-CIP10a cDNA for all further studies.

Structure Predicted for the P-CIP10 Protein

P-CIP10a encodes a protein of 1899 amino acids with a calculated molecular mass of 217 kDa and pI of 5.67 (Fig. 2D). P-CIP10 is largely hydrophilic, with the characteristics of a cytosolic protein. The NH2 terminus of P-CIP10 lacks a hydrophobic signal sequence, and no hydrophobic stretches typical of transmembrane domains are present. By homology search and computer-based structural analysis, P-CIP10 can be divided into five regions: a short NH2-terminal region, a region of spectrin-like repeats, a DH domain, a PH domain, and the COOH-terminal region (Fig. 2E).

The NH2-terminal 150 amino acids of P-CIP10 are homologous to Trio, a new member of the Dbl family of proteins identified by virtue of its interaction with the cytosolic domain of the leukocyte common antigen-related (LAR) transmembrane protein-tyrosine phosphatase (33). The next 1000 amino acid residues of P-CIP10 are most homologous to Trio (33), spectrin, and fodrin (34, 35). Spectrin and fodrin are cytoskeletal proteins involved in the maintenance of plasma membrane structure by cross-linking to actin and to various integral and membrane-associated proteins (36, 37). Secondary structure predictions indicate that this region of P-CIP10 is almost entirely alpha -helical and that the NH2-terminal part of P-CIP10 can be arranged into nine spectrin-like repeats 103-138 amino acids in length (Figs. 2E and 3A).


Fig. 3. Analysis of P-CIP10 amino acid sequence. A, the sequences of the nine spectrin-like repeats in P-CIP10 are aligned. The consensus features defining the A, B, and C helices of a spectrin-like unit (68) are indicated above the sequence of P-CIP10. Amino acids conforming to these rules are shown in boldface type. Hydrophobic residues are indicated by asterisks. Residues at a and d positions are generally hydrophobic. The number to the right of each sequence indicates the final residue of that repeat. B, alignment (Clustal) of DH and PH domains of P-CIP10 with related proteins, Trio (33), Dbs (40), Ost (38), Dbl (39), SCD1 (43), FGD1 (42), and Tiam (41). The only adjustments made to the alignment were in region 1 of the PH domain. DH domains start from residue 1258 for P-CIP10a, 1237 for Trio, 446 for Ost, 636 for Dbs, 499 for Dbl, 194 for SCD1, 376 for FGDL, and 1044 for Tiam. The six structural regions forming a PH domain are as defined (44, 46).
[View Larger Version of this Image (74K GIF file)]

Separated from the spectrin-like repeats by 50 amino acids is a 200-amino acid region (aa 1258-1457) with significant homology to the DH domain defined by Dbl, Dbs, and Ost (24, 38-40) (Fig. 2, D and E, and Fig. 3B). DH domains were identified first in a family of oncogenic proteins and subsequently shown to catalyze the exchange of bound GDP for bound GTP on specific members of the Rho subfamily of small GTP binding proteins (24). The DH domain with the highest homology to the DH domain of P-CIP10 is the first DH domain of human Trio (90% identity) (Fig. 3B). The DH domains of Dbl, Ost, and Dbs share 42-46% identity with that of P-CIP10. Additional proteins that share significant homology with the DH domain of P-CIP10 include Tiam, FGD1, and yeast SCD1 (Fig. 3B) (41-43).

The region of P-CIP10 immediately following the DH domain (Fig. 2, D and E; aa 1458-1555) constitutes a PH domain. PH domains are poorly conserved in sequence and are defined by their common three-dimensional structural motifs (44, 45). The PH domain of P-CIP10 has greatest similarity to the PH domain of Trio, followed by the PH domains of Dbl, Dbs, and Ost (Fig. 3B). Although not essential for in vitro GEF activity, the PH domain is generally essential to cellular function (46). PH domains are thought to aid in protein localization by protein-protein or protein-lipid interaction (44, 45, 47).

Except at its extreme COOH terminus, P-CIP10 exhibits homology to Trio. The COOH-terminal third of the 2861-amino acid Trio protein contains a second DH/PH domain, immunoglobulin-like repeats, and a putative serine/threonine protein kinase domain and these last two domains bear no homology to P-CIP10. Since the human ESTs identified as homologues of P-CIP10 (Fig. 2D) exhibit a greater degree of identity to rat P-CIP10 than does human Trio, we conclude that Trio and P-CIP10 are encoded by separate genes. The sequence homology exhibited by P-CIP10 and Trio suggests that these two proteins define a subfamily of the Dbl proteins.

Expression of P-CIP10 in AtT-20 Cells

To study the properties of P-CIP10 and its effects on cellular function, P-CIP10a and Myc.P-CIP10 cDNAs (Fig. 2A) were used to doubly transfect AtT-20 cells stably expressing PAM-1 (AtT-20/PAM-1 cells). AtT-20 corticotrope tumor cells do not express P-CIP10 at a level that allows detection by Northern blot analysis of total RNA (data not shown). Although the transfected P-CIP10 mRNA could easily be visualized by analyzing 10 µg of total RNA, the P-CIP10 protein proved difficult to detect. At least two clonal cell lines expressing P-CIP10 and two expressing Myc.P-CIP10 were selected based on Northern blot analysis and one of each was studied in detail.

Direct visualization of P-CIP10 proved impossible with available antisera, so we concentrated the Myc.P-CIP10 protein by immunoprecipitation. Extracts of AtT-20/PAM-1 cells expressing Myc.P-CIP10 were adsorbed to Myc monoclonal antibody immobilized on Protein G beads. Bound proteins were subjected to Western blot analysis and visualized with a rabbit polyclonal antiserum to P-CIP10 (aa 447-1138) (17) (Fig. 4A). A cross-reactive protein of 210 kDa was detected in cells expressing Myc.P-CIP10 but not in AtT-20/PAM-1 cells.


Fig. 4. Expression of P-CIP10. A, extracts of AtT-20 cells expressing PAM-1 alone or PAM-1 and Myc.P-CIP10 were incubated with Myc mAb bound to Protein G-Sepharose. The bound proteins were resolved by SDS-PAGE and visualized with P-CIP10 antibody JH2000. B, AtT-20/PAM-1 cells expressing P-CIP10a (lane 1), no additional protein (lane 2), or Myc.P-CIP10 (lane 3) were incubated in medium containing [35S]Met/Cys for 15 min. P-CIP10 proteins were immunoprecipitated from cell extracts using P-CIP10 antibody JH2000. C, AtT-20/PAM-1 cells expressing P-CIP10 were incubated in medium containing [35S]Met/Cys for 15 min (P) and chased for 1, 2, or 4 h before immunoprecipitation of P-CIP10. D, data for AtT-20 cells expressing P-CIP10 and Myc.P-CIP10 were densitized and normalized to the amount of P-CIP10 present after the pulse (n = 3). E, biosynthetically labeled AtT-20 cells expressing Myc.P-CIP10 were subjected to subcellular fractionation; Myc.P-CIP10 was immunoprecipitated (Ab JH2000) from resuspended particulate fractions (1000 × g for 5 min (P1), 4000 × g for 15 min (P2), 37,000 × g for 15 min (P3), and 435,000 × g for 15 min (P4)) and the final supernatant (S); proteins were visualized by fluorography. All results were replicated three times.
[View Larger Version of this Image (59K GIF file)]

Expression of P-CIP10 in AtT-20 cells could also be demonstrated by metabolic labeling and immunoprecipitation. AtT-20/PAM-1 cells expressing P-CIP10, Myc.P-CIP10, or only PAM-1 were incubated in medium containing [35S]Met/Cys for 15 min, extracted, and subjected to immunoprecipitation using antibody to recombinant GST.P-CIP10 (aa 447-1138) (Fig. 4B). A radiolabeled protein of 210 kDa was detected in both P-CIP10 lines and accounted for 0.03 ± 0.01% of the total protein synthesized during a 30-min pulse. The fact that P-CIP10 was more easily identified using metabolic labeling methods suggested that the protein might have a short half-life. Using a pulse/chase paradigm, both P-CIP10a and Myc.P-CIP10 were found to turn over quickly (Fig. 4C). A semilogarithmic plot of the densitized band intensities yielded a half-life estimate of 60 min for both proteins (Fig. 4D).

To localize P-CIP10, AtT-20/PAM-1 cells expressing Myc.P-CIP10 were biosynthetically labeled for 30 min and subjected to differential centrifugation (Fig. 4E). PAM-1 is recovered in fractions enriched in endoplasmic reticulum (P1 and P2) as well as in fractions enriched in TGN (P2 and P3) and secretory granules (P3). Each particulate fraction as well as the cytosolic fraction contained Myc.P-CIP10. The association of P-CIP10 with particulate fractions, many of which contain intact PAM-1 (23), suggests that P-CIP10 may function by interacting with membranous organelles.

Expression of P-CIP10 Changes AtT-20 Cell Morphology

Since many members of the Dbl family of proteins interact with members of the Rho family of GTPases and affect cytoskeletal organization and cell shape (48, 49), we examined the morphology of our stably transfected AtT-20 cells (Fig. 5). Many cells expressing P-CIP10 were larger than wild type AtT-20 or AtT-20/PAM-1 cells. In addition, cells expressing P-CIP10 often had very long processes, some of which were branched. Photomicrographs of randomly selected fields of each cell type were analyzed; the number of giant cells, the percentage of cells having neuritic processes, and the lengths and shapes of processes were quantified (Fig. 5E). Approximately 15% of the total population of P-CIP10-expressing cells had greatly enlarged cell bodies, 5-6 times more than for nontransfected as well as for the PAM-1-expressing cells. Twice as many of the P-CIP10-expressing cells had processes, although the average number of processes per cell for cells with processes was unaltered. The percentage of branched processes and the percentage of processes longer than 100 µm were dramatically increased for the cells expressing P-CIP10.


Fig. 5. Expression of P-CIP10 affects the morphology of AtT-20/PAM-1 cells. Nontransfected AtT-20 cells, AtT-20 cells stably expressing PAM-1, and AtT-20 cells stably expressing both PAM-1 and P-CIP10a or Myc.P-CIP10 were photographed without fixation. Five photographs of each cell type were used to measure the length of neuritic processes, number of giant cells, and number of processes with branches or bifurcations. Samples statistically different from nontransfected cells are indicated by asterisks (p < 0.02, t test). The entire analysis was repeated on an independent set of cells with the same results.
[View Larger Version of this Image (91K GIF file)]

Expression of P-CIP10 Alters the Metabolism of PAM-1

In AtT-20 cells, the 120-kDa PAM-1 protein is cleaved by neuroendocrine-specific endoproteases after it exits the TGN (50). Cleavage yields soluble 45-kDa PHM and a 70-kDa membrane protein containing the PAL, transmembrane, and COOH-terminal cytosolic domains. Active, 45-kDa PHM is stored in large dense core vesicles from which its secretion can be regulated by secretagogues. Membrane PAM proteins that are localized to the cell surface can be cleaved at a site near the transmembrane domain, leading to the accumulation of bifunctional 105-kDa PAM in the medium (8).

To determine whether expression of P-CIP10 changed the metabolism of PAM-1, we performed pulse/chase metabolic labeling experiments on AtT-20/PAM-1 cells and AtT-20/PAM-1 cells expressing P-CIP10a or Myc.P-CIP10. Quadruplicate wells of each cell type were incubated in medium containing [35S]Met/Cys and either harvested immediately (P; pulse) or incubated in the presence of unlabeled methionine/cysteine for 1, 2, or 4 h (C; chase) (Fig. 6). Full-length PAM-1 (120 kDa) disappeared more rapidly from cells expressing P-CIP10 than from PAM-1 cells (Fig. 6A). Consistent with this, production of 45-kDa PHM occurred at a slightly earlier time in cells expressing P-CIP10 (Fig. 6A; 45 kDa). The total amount of PAM protein recovered after 4 h of chase was less in AtT-20/PAM-1 cells expressing P-CIP10. More bifunctional 105-kDa PAM accumulated in the medium of cells expressing PAM-1 than in the medium of cells expressing PAM-1 and P-CIP10 (Fig. 6B; 105 kDa).


Fig. 6. Expression of P-CIP10 affects the metabolism of PAM-1. A, AtT-20 cells expressing only PAM-1 (PAM-1 cells), PAM-1 with P-CIP10a (P-CIP10a cells), and PAM-1 with Myc.P-CIP10 (Myc.P-CIP10 cells) were incubated with [35S]Met/Cys for 15 min and harvested immediately (P) or incubated in the presence of unlabeled Met/Cys for 2 h prior to harvest. PAM proteins were immunoprecipitated from detergent-solubilized cell extracts (C) and medium (M) using a PHM antibody. B, PAM proteins were immunoprecipitated from medium samples obtained after a 4-h chase of cells labeled as described above. The entire analysis was replicated three times; the asterisk indicates nonspecific bands (8, 9).
[View Larger Version of this Image (33K GIF file)]

P-CIP10 Interacts with Rac1 GTPase

The presence of a DH domain followed by a PH domain in P-CIP10 strongly suggested that it would interact with members of the Rho subfamily of small GTP-binding proteins (48, 49). The GST fusion proteins of Rac1, RhoA, and Cdc42 were depleted of nucleotide, bound to glutathione-Sepharose, and incubated with extracts of AtT-20 cells expressing PAM-1 or PAM-1/Myc.P-CIP10. The bound proteins were analyzed by Western blot or by immunoprecipitation. Extracts of AtT-20 PAM-1/P-CIP10 cells contained a 210-kDa protein that bound to Rac1 but not to RhoA or Cdc42 (Fig. 7). Binding occurred in the absence of bound nucleotide and was not observed when extracts of control AtT-20 PAM-1 cells were used. We conclude that P-CIP10 is capable of interacting specifically with Rac1.


Fig. 7. P-CIP10 Binds to Rac1. A, extracts of AtT-20 cells expressing only PAM-1 or PAM-1 and Myc.P-CIP10 were incubated with guanine-nucleotide-depleted GST-Rac1, -RhoA, and -Cdc42 bound to glutathione-Sepharose. As a positive control, Myc mAb bound to Protein G-Sepharose beads was used to bind Myc.P-CIP10 from an equal aliquot of cell extract. GST-glutathione-Sepharose beads were used as negative control. Proteins eluted from the resin were subjected to Western blot analysis and visualized with Ab JH2000. B, AtT-20 cells expressing PAM-1 or PAM-1 and Myc.P-CIP10 were incubated with [35S]Met/Cys for 6 h, and extracts were preadsorbed on GST-glutathione-Sepharose beads and then incubated with GST-Rac1, -RhoA, and -Cdc42 bound to glutathione-Sepharose beads. Bound proteins were eluted, and Myc.P-CIP10 was immunoprecipitated with Ab JH2000 (IPT).
[View Larger Version of this Image (34K GIF file)]


DISCUSSION

Since our previous mutagenesis studies identified the CD of membrane PAM as essential in establishing its steady state localization in neuroendocrine cells, we screened a rat hippocampal cDNA library for PAM CD interactors using the yeast two-hybrid system (17). We previously identified partial cDNAs encoding a putative protein serine/threonine kinase (P-CIP2) and a protein with spectrin-like repeats (P-CIP10). Elucidation of the complete structure of P-CIP10 revealed the presence of elements common to signal transduction pathways, and expression of P-CIP10 in AtT-20 cells altered PAM processing and cell morphology. The itinerary taken by membrane PAM proteins in AtT-20 cells is complex, and it is anticipated that additional proteins capable of interacting with the CD of PAM will be identified.

The expression of P-CIP10 is highest in specific areas of rat brain. PAM is expressed in the same areas, but PAM is also expressed at high levels in many tissues lacking P-CIP10. For example, atrium, anterior, and neurointermediate pituitary express little P-CIP10 but high levels of PAM. P-CIP10 may fulfill a function unique to its sites of expression, or homologous protein(s) may be involved in the routing of PAM in tissues lacking P-CIP10. The existence of P-CIP10 transcripts with different 5'-ends and different sizes suggests that alternate splicing generates diverse forms of P-CIP10. Routing signals in the CD of PAM are recognized in both neuroendocrine and nonneuroendocrine cells (7, 8), and proteins homologous to P-CIP10, but expressed more widely, may be involved in these interactions.

The co-expression of P-CIP10 and PAM-1 in AtT-20 cells increased the rate and extent of disappearance of newly synthesized PAM-1. After traversing the Golgi stacks, newly synthesized membrane PAM exits the TGN and enters immature secretory granules (50). Although some membrane PAM remains in mature secretory granules, most of the membrane PAM leaves the immature granules, perhaps via constitutive-like vesicles. Membrane PAM that reaches the cell surface is efficiently internalized, with mutagenesis studies suggesting that access to lysosomes is affected by phosphorylation (23). The phenotype observed suggests that P-CIP10 affects routing of PAM in the TGN/immature secretory granule region of the cell. P-CIP10 protein, which turns over with a half-life of less than 1 h, was recovered in particulate fractions and in cytosol, and factors affecting its interaction with particulate fractions remain to be identified.

The structure of P-CIP10, a member of the growing Dbl family of proteins, provides a great deal of insight into its possible functions (24, 51). The first members of this family, Dbl, Dbs, and Ost, were identified by their oncogenic activity. Family members share DH and PH homology domains, and most have been shown to serve as GDP/GTP exchange factors for specific members of the Rho family of small GTP-binding proteins. Oncogenic forms of Dbl family members often lack NH2-terminal regulatory domains, and the effect of expressing P-CIP10 lacking this region remains to be investigated. Trio, which is broadly expressed, is most closely related to P-CIP10 (33). Trio was identified by virtue of the interaction of its COOH-terminal domain with the cytosolic domain of the LAR receptor type protein-tyrosine phosphatase (33); characterized forms of P-CIP10 lack a homologous region. Phogrin, a homologue of the LAR protein-tyrosine phosphatase, is localized to the regulated secretory pathway of neuroendocrine cells (52), and several other receptor type protein-tyrosine phosphatases are neuroendocrine-specific, raising the possibility that they interact with P-CIP10-related molecules (53-55).

The NH2-terminal half of P-CIP10 contains 9 units homologous to the 5-nm-long structural units that make up spectrin (68). Spectrins provide structural support to the plasma membrane and form an extensive cytoskeletal meshwork by binding to specific soluble and integral membrane proteins (36, 37, 56). The spectrin-based membrane skeleton restricts the mobility of membrane proteins. An isoform of beta -spectrin associated with Golgi membranes in Madin-Darby canine kidney cells may play a role in sorting proteins into the vesicular transport pathway (57). The fact that P-CIP10 expression facilitates cleavage of newly synthesized PAM by enzymes located in immature secretory granules identifies the TGN/immature secretory granule as a subcellular site at which PAM/P-CIP10 interactions occur.

The DH/PH domain of P-CIP10 is most homologous to the first DH/PH domain of human Trio (33). Consistent with this homology, P-CIP10 binds to Rac1 but not to RhoA or Cdc42. Many members of the Dbl family, through their DH/PH domain, act as GDP/GTP exchange factors for members of the Rho family of small GTP binding proteins and play important roles in regulating cytoskeletal organization (49, 58). The ability of P-CIP10 to act as a GDP/GTP exchange factor remains to be tested. The PH domain of known Dbl family members is generally not essential for in vitro GDP/GTP exchange factor activity, but it is essential for cellular function (46, 59). PH domains and the structurally related phosphotyrosine binding domains can bind specific lipids, phosphopeptides, or proteins, targeting the neighboring DH domain to the proper subcellular location (45, 46, 60). The COOH-terminal region of P-CIP10 retains some homology to the corresponding region of Trio but shows no homology to other proteins in the data base.

Expression of P-CIP10 in AtT-20 cells was associated with the presence of more giant cells, more cells with neuritic processes, and more long processes that branched. Although the underlying mechanisms are not clear, the fact that P-CIP10 interacts with Rac1 is consistent with the occurrence of cytoskeletal effects. In Drosophila, Rac1 affects axonal but not dendritic outgrowth (61), and expression of constitutively active Rac1 in the Purkinje cells of transgenic mice alters both axonal and dendritic morphology (62). In fibroblasts, Rac1 regulates formation of lamellipodia and membrane ruffling (49). Rac1 has been shown to interact with a variety of protein and lipid kinases, thus affecting actin cytoskeletal organization, transcriptional activation, cell proliferation, and secretion (49, 58, 63, 64). Studies using perforated cells demonstrated an inhibitory role for Rac and Rho in transferrin receptor-mediated endocytosis through coated pits (65), and kinectin, a vesicle membrane anchoring protein for kinesin binds activated Rac (66). Overexpression of Tiam1 or activated Rac1 in T-lymphoma cells induced invasiveness (67).

Perhaps most intriguing about the identification of a Dbl family member as a PAM CD interactor is the possibility that we have identified a signal transduction pathway linking the lumen of the secretory pathway to the cytosol. P-CIP10, a putative GDP/GTP exchange factor, interacts with integral membrane PAM, whose pH and conformation-sensitive functional domains (27) reside in the lumen of the regulated secretory pathway, and with Rac1, a small GTP-binding protein that is a component of several distinct cytosolic signal transduction pathways. These interactions suggest a relationship between large dense core vesicle biogenesis and the signal transduction machinery. Identification of additional large dense core vesicle and cytosolic interactors with P-CIP10 and studies on the effects of P-CIP10 on signal transduction pathways regulated by Rho-like GTPases should provide a mechanistic understanding of the biogenesis and routing of large dense core vesicles. We propose giving P-CIP10 the name kalirin to signify its ability to interact with multiple proteins (Kali, Hindu goddess with many hands) and its spectrin-like domains.


FOOTNOTES

*   This work was supported by National Institutes of Health Grants DK-32949 and 32948.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed: 907 Wood Basic Science Bldg., The Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD 21205-2105. Tel.: 410-955-6937; Fax: 410-955-0681; E-mail: betty.eipper{at}jhu.edu.
1   The abbreviations used are: PAM, peptidylglycine alpha -amidating monooxygenase; TGN, trans-Golgi network; kb, kilobase pair(s); RHP, RACE hybrid primer; PCR, polymerase chain reaction; pBS, pBluescript II (SK-); aa, amino acids; nt, nucleotide(s); DH, Dbl homology; PH, pleckstrin homology; PAGE, polyacrylamide gel electrophoresis; TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid; Ab, antibody; mAb, monoclonal antibody; EST, expressed sequence tag; GST, glutathione S-transferase; CD, cytosolic domain; LAR, leukocyte common antigen-related; MCS, multiple cloning site.

ACKNOWLEDGEMENTS

We thank Dr. Richard Cerione and Dr. Shubha Bagrodia (Cornell University) for providing the GST-Rac1, RhoA, and Cdc42 expression vectors and Dr. Henry Keutmann (Massachusetts General Hospital) for synthesizing the P-CIP10 peptide. We thank Marie Bell for helping with all aspects of this work and Kate Deanehan for help developing the monoclonal antibody.


REFERENCES

  1. Barr, F. A., Leyte, A., and Huttner, W. B. (1992) Trends Cell Biol. 2, 91-94 [Medline] [Order article via Infotrieve]
  2. Ohashi, M., and Huttner, W. B. (1996) J. Biol. Chem. 269, 24897-24905 [Abstract/Free Full Text]
  3. Chen, Y.-G., and Shields, D. (1996) J. Biol. Chem. 271, 5297-5300 [Abstract/Free Full Text]
  4. Miller, S. G., Carnell, L., and Moore, H. P. (1993) J. Cell Biol. 118, 267-283 [Abstract]
  5. Chen, Y. T., Holcomb, C., and Moore, H. P. H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 6508-6512 [Abstract]
  6. Tooze, S. A. (1991) FEBS Lett. 285, 220-224 [CrossRef][Medline] [Order article via Infotrieve]
  7. Tausk, F. A., Milgram, S. L., Mains, R. E., and Eipper, B. A. (1992) Mol. Endocrinol. 6, 2185-2196 [Abstract]
  8. Milgram, S. L., Mains, R. E., and Eipper, B. A. (1993) J. Cell Biol. 121, 23-35 [Abstract]
  9. Milgram, S. L., Mains, R. E., and Eipper, B. A. (1996) J. Biol. Chem. 271, 17526-17535 [Abstract/Free Full Text]
  10. Molloy, S. S., Thomas, L., VanSlyke, J. K., Stenberg, P. E., and Thomas, G. (1994) EMBO J. 13, 18-33 [Abstract]
  11. Jones, B. G., Thomas, L., Molloy, S. S., Thulin, C. D., Fry, M. D., Walsh, K. A., and Thomas, G. (1995) EMBO J. 14, 5869-5883 [Abstract]
  12. Ohno, H., Stewart, J., Fournier, M.-C., Bosshart, H., Rhee, I., Miyatake, S., Saito, T., Gallusser, A., Kirchhausen, T., and Bonifacino, J. S. (1995) Science 269, 1872-1875 [Medline] [Order article via Infotrieve]
  13. Voorhees, P., Deignan, E., van Donselaar, E., Humphrey, J. S., Marks, M. S., Peters, P. J., and Bonifacino, J. S. (1995) EMBO J. 14, 4961-4975 [Abstract]
  14. Schafer, W., Stroh, A., Berghofer, S., Seiler, J., Vey, M., Kruse, M.-L., Kern, H. F., Klenk, H.-D., and Garten, W. (1995) EMBO J. 14, 2424-2435 [Abstract]
  15. Bajjalieh, S. M., and Scheller, R. H. (1995) J. Biol. Chem. 270, 1971-1974 [Free Full Text]
  16. Takahashi, S., Nakagawa, T., Banno, T., Watanabe, T., Murakami, K., and Nakayama, K. (1995) J. Biol. Chem. 270, 28397-29401 [Abstract/Free Full Text]
  17. Alam, M. R., Caldwell, B. D., Johnson, R. C., Darlington, D. N., Mains, R. E., and Eipper, B. A. (1996) J. Biol. Chem. 271, 28636-28640 [Abstract/Free Full Text]
  18. Eipper, B. A., Milgram, S. L., Husten, E. J., Yun, H.-Y., and Mains, R. E. (1993) Protein Sci. 2, 489-497 [Abstract/Free Full Text]
  19. Bradbury, A. F., and Smyth, D. G. (1991) Trends Biochem. Sci. 16, 112-115 [CrossRef][Medline] [Order article via Infotrieve]
  20. Schnabel, E., Mains, R. E., and Farquhar, M. G. (1989) Mol. Endocrinol. 3, 1223-1235 [Abstract]
  21. Milgram, S. L., Kho, S. T., Martin, G. V., Mains, R. E., and Eipper, B. A. (1997) J. Cell Sci. 110, 695-706 [Abstract/Free Full Text]
  22. Milgram, S. L., Johnson, R. C., and Mains, R. E. (1992) J. Cell Biol. 117, 717-728 [Abstract]
  23. Yun, H.-Y., Milgram, S. L., Keutmann, H. T., and Eipper, B. A. (1995) J. Biol. Chem. 270, 30075-30083 [Abstract/Free Full Text]
  24. Cerione, R. A., and Zheng, Y. (1996) Curr. Op. Cell Biol. 8, 216-222 [CrossRef][Medline] [Order article via Infotrieve]
  25. Johnson, R. C., Darlington, D. N., Hand, T. A., Bloomquist, B. T., and Mains, R. E. (1994) Endocrinology 135, 1178-1185 [Abstract]
  26. Paquet, L., Massie, B., and Mains, R. E. (1996) J. Neurosci. 16, 964-973 [Abstract]
  27. Husten, E. J., Tausk, F. A., Keutmann, H. T., and Eipper, B. A. (1993) J. Biol. Chem. 268, 9709-9717 [Abstract/Free Full Text]
  28. Borjigin, J., and Nathans, J. (1994) J. Biol. Chem. 269, 14715-14722 [Abstract/Free Full Text]
  29. Hart, M. J., Sharma, S., elMasry, N., Qiu, R.-G., McCabe, P., Polakis, P., and Bollag, G. (1996) J. Biol. Chem. 271, 25452-25458 [Abstract/Free Full Text]
  30. Hart, M. J., Eva, A., Zangrilli, D., Aaronson, S. A., Evans, T., Cerione, R. A., and Zheng, Y. (1994) J. Biol. Chem. 269, 62-65 [Abstract/Free Full Text]
  31. Kozak, M. (1991) J. Cell Biol. 115, 887-903 [Abstract]
  32. Kozak, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2662-2666 [Abstract]
  33. Debant, A., Serra-Pages, C., Seipel, K., O'Brien, S., Tang, M., Park, S.-H., and Streuli, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5466-5471 [Abstract/Free Full Text]
  34. Bloom, M. L., Birkenmeier, C. S., and Baker, J. E. (1993) Blood 82, 2906-2914 [Abstract]
  35. Winkelmann, J. C., Chang, J.-G., Tse, W. T., Scarpa, A. L., Marchesi, V. T., and Forget, B. G. (1990) J. Biol. Chem. 265, 11827-11832 [Abstract/Free Full Text]
  36. Bennett, V., and Gilligan, D. M. (1993) Annu. Rev. Cell Biol. 9, 27-66 [CrossRef]
  37. Viel, A., and Branton, D. (1996) Curr. Op. Cell Biol. 8, 49-55 [CrossRef][Medline] [Order article via Infotrieve]
  38. Horii, Y., Beeler, J. F., Sakaguchi, K., Tachibana, M., and Miki, T. (1994) EMBO J. 13, 4776-4786 [Abstract]
  39. Ron, D., Tronick, S. R., Aaronson, S. A., and Eva, A. (1988) EMBO J. 7, 2465-2473 [Abstract]
  40. Whitehead, I., Kirk, H., and Kay, R. (1995) Oncogene 10, 713-721 [Medline] [Order article via Infotrieve]
  41. Habets, G. G. M., Scholtes, E. H. M., Zuydgeest, D., van der Kammen, R. A., Stam, J. C., Berns, A., and Collard, J. G. (1995) Cell 77, 537-549
  42. Pasteris, N. G., Cadle, A., Logie, L. J., Porteous, M. E., Schwartz, C. E., Stevenson, R. E., Glover, T. W., Wilroy, R. S., and Gorski, J. L. (1994) Cell 79, 669-678 [Medline] [Order article via Infotrieve]
  43. Chang, E. C., Barr, M., Wang, Y., Jung, V., Xu, H.-P., and Wigler, M. H. (1995) Cell 79, 131-141
  44. Shaw, G. (1995) BioEssays 18, 35-46
  45. Lemmon, M. A., Ferguson, K. M., and Schlessinger, J. (1996) Cell 85, 621-624 [Medline] [Order article via Infotrieve]
  46. Zheng, Y., Zangrilli, D., Cerione, R. A., and Eva, A. (1996) J. Biol. Chem. 271, 19017-19020 [Abstract/Free Full Text]
  47. Lemmon, M. A., Ferguson, K. M., O'Brien, R., Sigler, P. B., and Schlessinger, J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10472-10476 [Abstract]
  48. Norman, J. C., Price, L. S., Ridley, A. J., and Koffer, A. (1996) Mol. Biol. Cell 7, 1429-1442 [Abstract]
  49. Ridley, A. J. (1996) Curr. Biol. 6, 1256-1264 [Medline] [Order article via Infotrieve]
  50. Milgram, S. L., Eipper, B. A., and Mains, R. E. (1994) J. Cell Biol. 124, 33-41 [Abstract]
  51. Quilliam, L. A., Khosravi-Far, R., Huff, S. Y., and Der, C. J. (1995) BioEssays 17, 395-404 [Medline] [Order article via Infotrieve]
  52. Wasmeier, C., and Hutton, J. C. (1996) J. Biol. Chem. 271, 18161-18170 [Abstract/Free Full Text]
  53. Cui, L., Yu, W.-P., DeAizpurua, H. J., Schmidli, R. S., and Pallen, C. J. (1996) J. Biol. Chem. 271, 24817-24823 [Abstract/Free Full Text]
  54. Bult, A., Zhao, F., Dirkx, R., Jr., Sharma, E., Lukacsi, E., Solimena, M., Naegele, J. R., and Lombroso, P. J. (1996) J. Neurosci. 16, 781-7831
  55. Lan, M. S., Lu, J., Goto, Y., and Notkins, A. L. (1994) DNA Cell Biol. 13, 505-514 [Medline] [Order article via Infotrieve]
  56. Lombardo, C. R., Weed, S. A., Kennedy, S. P., Forget, B. G., and Morrow, J. S. (1994) J. Biol. Chem. 269, 29212-29219 [Abstract/Free Full Text]
  57. Beck, K. A., Buchanan, J. A., Malhotra, V., and Nelson, W. J. (1994) J. Cell Biol. 127, 707-723 [Abstract]
  58. Joneson, T., McDonough, M., Bar-Sagi, D., and Van Aelst, L. (1996) Science 274, 1374-1376 [Abstract/Free Full Text]
  59. Whitehead, I. P., Khosravi-Far, R., Kirk, H., Trgio-Gonzalez, G., Der, C. J., and Kay, R. (1996) J. Biol. Chem. 271, 18643-18650 [Abstract/Free Full Text]
  60. Lukowski, S., Lecomete, M.-C., Mira, J.-P., Marin, P., Gautero, H., Russo-Marie, F., and Geny, B. (1996) J. Biol. Chem. 271, 24164-24171 [Abstract/Free Full Text]
  61. Luo, L., Liao, Y. J., Jan, L. Y., and Jan, Y. N. (1997) Genes Dev. 8, 1787-1802 [Abstract]
  62. Luo, L., Hensch, T. K., Ackerman, L., Barbel, S., Jan, L. Y., and Jan, Y. N. (1996) Nature 379, 837-840 [CrossRef][Medline] [Order article via Infotrieve]
  63. Vojtek, A. B., and Cooper, J. A. (1995) Cell 82, 527-529 [Medline] [Order article via Infotrieve]
  64. Burbelo, P. D., Drechsel, D., and Hall, A. (1995) J. Biol. Chem. 270, 29071-29074 [Abstract/Free Full Text]
  65. Lamaze, C., Chuang, T.-H., Terlecky, L. J., Bokoch, G. M., and Schmid, S. L. (1996) Nature 382, 177-179 [CrossRef][Medline] [Order article via Infotrieve]
  66. Hotta, K., Tanaka, K., Mino, A., Kohno, H., and Takai, Y. (1996) Biochem. Biophys. Res. Commun. 225, 69-74 [CrossRef][Medline] [Order article via Infotrieve]
  67. Michiels, F., Habets, G. G. M., Stam, J. C., van der Kammen, R. A., and Collard, J. G. (1995) Nature 375, 338-340 [CrossRef][Medline] [Order article via Infotrieve]
  68. Yan, Y., Winograd, E., Viel, A., Cronin, T., Harrison, S. C., and Branton, D. (1993) Science 262, 2027-2030 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.